Integrated Biopharma Inc (INBP) financials · rev $34.1M
Integrated Biopharma Inc (INBP) rev $34.1M.
| Line | FY2025 |
|---|---|
| Revenue | $54.4M |
| Cost of Revenue | $48.8M |
| Gross Profit | $5.6M |
| Operating Income | $2.0M |
| Net Income | $808.0K |
| EPS (Diluted) | $0.03 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $24.9M | $26.2M |
| Current Assets | $18.8M | $17.9M |
| Cash & Equivalents | $3.6M | $1.7M |
| Inventory | $9.4M | $11.2M |
| PP&E | $1.7M | $1.9M |
| Total Liabilities | $4.6M | $7.0M |
| Current Liabilities | $4.2M | $6.1M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $20.3M | $19.2M |
| Retained Earnings | -$31.4M | -$32.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $2.1M | $943.0K |
| CapEx | $191.0K | $553.0K |
| Investing Cash Flow | -$205.0K | -$553.0K |
| Financing Cash Flow | $78.0K | -$29.0K |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $1.9M | $361.0K |
| Free Cash Flow | $1.9M | $390.0K |
FAQ
What is INBP P/E and revenue?
Integrated Biopharma Inc (INBP) rev $34.1M.
What is INBP revenue?
Integrated Biopharma Inc last cached revenue is $54.4M (FY2025).
Is INBP profitable?
Integrated Biopharma Inc last cached net income is $808.0K.
What are INBP total assets?
Integrated Biopharma Inc last cached total assets are $24.9M.
What is INBP free cash flow?
Integrated Biopharma Inc last cached free cash flow is $1.9M.
Not investment advice. Cached statements, not a live tape.